Integration of Immune Effector Cellular Therapy into a FACT-Accredited Transplant Program presented by Dr. Carlos Bachier
In This Issue
- Just the FACTs, Volume 3
- FACT COVID-19 Resources
- United States Food and Drug Administration Issues Guidance on COVID-19 Convalescent Plasma
- New Product Description Codes for Convalescent Plasma COVID-19
- Integration of Immune Effector Cellular Therapy into a FACT-Accredited Transplant Program presented by Dr. Carlos Bachier
- Canceled: FACT Cellular Therapy Collection Inspection and Accreditation Workshop
- Canceled: FACT Cord Blood Inspection and Accreditation Workshop at ISCT Annual Meeting
- FACT Cord Blood Inspection and Accreditation Workshop at the 2020 Cord Blood Connect International Congress on Hold
Accreditation Statistics
As of August 1, 2023
Cellular Therapy Entities
- Accredited: 255
- Applicants: 26
Cord Blood Banks
- Accredited: 53
- Applicants: 9
Congratulations to the following organizations for achieving initial accreditation:
Pennsylvania Hospital, Penn Medicine: Adult autologous hematopoietic progenitor cellular therapy, peripheral blood cellular therapy product collection, and cellular therapy product processing with minimal manipulation
Sarah Cannon Transplant & Cellular Therapy Program at MountainView Hospital: Adult autologous hematopoietic progenitor cellular therapy, immune effector cellular therapy administration, peripheral blood cellular therapy product collection, and cellular therapy product processing with minimal manipulation
A complete list of accredited organizations can be found at www.factglobal.org.
